(Q63778882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14405871%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14405871%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25) (English)

1 reference

lysergic acid diethylamide

27 February 2024

main subject

0 references

1 reference

27 February 2024

author name string

H. ISBELL

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14405871

27 February 2024

E. J. MINER

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14405871

27 February 2024

C. R. LOGAN

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14405871

27 February 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14405871

27 February 2024

publication date

1 November 1959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14405871%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 December 2019

http://link.springer.com/content/pdf/10.1007/BF00409110.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00409110/fulltext.html

27 February 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF00409110

27 February 2024

1 reference

27 February 2024

0 references

1

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14405871

27 February 2024

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14405871%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

2

0 references

page(s)

109-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14405871%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00409110

16 December 2019

exact match

0 references

cites work

Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.

1 reference

12 December 2020

Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25)

1 reference

12 December 2020

Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148).

1 reference

12 December 2020

Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

1 reference

12 December 2020

LYSERGIC ACID DIETHYLAMIDE AND RELATED SUBSTANCES

1 reference

12 December 2020

Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide)

1 reference

12 December 2020

Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25)

1 reference

12 December 2020

Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs

1 reference

12 December 2020

Journal of Pharmacology and Experimental Therapeutics

13

98

305

C. A. Winter

1950

1 reference